Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-22

Clinical Trial Update: Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effect of Momordica charantia on type 2 diabetes mellitus, insulin sensitivity, and insulin secretion; completed with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Momordica charantia (Momordica charantia)

Snippet

Sponsor: University of Guadalajara | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-10-22